These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1909228)

  • 1. Outcome of a ceftriaxone/cefotaxime interchange programme in a major teaching hospital.
    Gutensohn A; Bunz D; Frighetto L; Jewesson P
    Chemotherapy; 1991; 37 Suppl 3():15-21. PubMed ID: 1909228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftriaxone compared with cefotaxime for serious bacterial infections.
    Smith CR; Petty BG; Hendrix CW; Kernan WN; Garver PL; Fox K; Beamer A; Carbone K; Threlkeld M; Lietman PS
    J Infect Dis; 1989 Sep; 160(3):442-7. PubMed ID: 2668428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefotaxime twice daily versus ceftriaxone once daily. A randomized controlled study in patients with serious infections.
    Simmons BP; Gelfand MS; Grogan J; Craft B
    Diagn Microbiol Infect Dis; 1995; 22(1-2):155-7. PubMed ID: 7587031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once-daily therapy with ceftriaxone compared with daily multiple-dose therapy with cefotaxime for serious bacterial infections: a randomized, double-blind study.
    Mandell LA; Bergeron MG; Ronald AR; Vega C; Harding G; Saginur R; Feld R; Duperval R; Landis SJ; Miedzinski LJ
    J Infect Dis; 1989 Sep; 160(3):433-41. PubMed ID: 2668427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of lower respiratory tract infections with ceftriaxone and cefotaxime. A comparative study.
    Abbate GF; Alagia I; Giaquinto E; Leonessa V; Savioli L; Altucci P; Caputi M; Guarino C; Micillo E; Catena E
    Respiration; 1986; 49(3):222-30. PubMed ID: 3515468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the efficacy and adverse effect profile of cefotaxime and ceftriaxone in ICU patients with susceptible infections.
    Thomas P; Daly S; Misan G; Steele T
    Diagn Microbiol Infect Dis; 1992 Jan; 15(1):89-97. PubMed ID: 1730190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter, open comparative study of parenteral cefotaxime and ceftriaxone in the treatment of nosocomial lower respiratory tract infections.
    Garber GE; Auger P; Chan RM; Conly JM; Shafran SD; Gerson M
    Diagn Microbiol Infect Dis; 1992 Jan; 15(1):85-8. PubMed ID: 1730189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective comparison of ceftriaxone and cefotaxime for the short-term treatment of bacterial meningitis in children.
    Scholz H; Hofmann T; Noack R; Edwards DJ; Stoeckel K
    Chemotherapy; 1998; 44(2):142-7. PubMed ID: 9551246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cost-effectiveness comparative study of ceftriaxone verus cefotaxime in the treatment of complicated urinary infections].
    Martínez Jabaloyas JM; Sanz Chinesta S; Jiménez Cruz JF; Flores Corral N; Unda Urzaiz M; Leiva Galvis O; González Romojaro V; Hernández Fernández C; Lledó García E; Rioja Sanz LA; Gonzalvo Ibarra A; Camacho González JE; Ruíz Alvárez-Cienfuegos F; Resel Estévez L; Corral Saleta J; Burgos Rodríguez R; Del Rosal Samaniego JM
    Actas Urol Esp; 1997; 21(7):668-74. PubMed ID: 9412209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic prophylaxis in the surgical treatment of peritrochanteric fractures: a comparative trial between two cephalosporins.
    Karachalios T; Lyritis GP; Hatzopoulos E
    Chemotherapy; 1990; 36(6):448-53. PubMed ID: 2292207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-shot treatment of uncomplicated gonorrhoea with third-generation cephalosporins with differing serum half-life. Results of a controlled trial with ceftriaxone and cefotaxime.
    Korting HC; Abeck D
    Chemotherapy; 1989; 35(6):441-8. PubMed ID: 2515041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of cefotaxime with ceftriaxone given intramuscularly 12-hourly for community-acquired pneumonia.
    Dansey RD; Jacka PJ; Strachan SA; Hay M
    Diagn Microbiol Infect Dis; 1992 Jan; 15(1):81-4. PubMed ID: 1730188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefotaxime. A pharmacoeconomic review of its use in the treatment of infections.
    Plosker GL; Foster RH; Benfield P
    Pharmacoeconomics; 1998 Jan; 13(1 Pt 1):91-106. PubMed ID: 10175990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefotaxime versus ceftriaxone for the treatment of nosocomial pneumonia. Results of a multicenter study.
    Shah PM; Stille W
    Diagn Microbiol Infect Dis; 1995; 22(1-2):171-2. PubMed ID: 7587035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ceftriaxone in the therapy of infections of the lower respiratory tract: comparison with cefotaxime].
    Lanni N; Scaglione B
    Minerva Med; 1986 Mar; 77(9-10):317-9. PubMed ID: 3485265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of intravenous ceftriaxone followed by oral cefixime versus ceftriaxone alone in the treatment of severe upper urinary tract infections].
    Regnier B
    Presse Med; 1989 Oct; 18(32):1617-21. PubMed ID: 2530546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefotaxime and ceftriaxone use evaluation in pediatrics. Considerations of cost effectiveness.
    Lee CK; Glenn DJ
    Diagn Microbiol Infect Dis; 1995; 22(1-2):231-3. PubMed ID: 7587045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy of lower respiratory tract infections: a comparison of ceftriaxone and cefotaxime.
    Barradas P; Zamith M; Videira W; Cardosa T; Marques RA; Avila R
    Chemotherapy; 1989; 35 Suppl 2():33-40. PubMed ID: 2612238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on the relationship between pharmacokinetics and antibacterial activity: comparison between ceftriaxone and cefotaxime within the respiratory tract.
    Fraschini F; Scaglione F
    Chemotherapy; 1989; 35(2):77-82. PubMed ID: 2758870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftriaxone once daily compared with four daily doses of cefotaxime in the treatment of severe gram-negative septicemia or pyemia: a randomized study.
    Leu HS; Lasserre R
    Changgeng Yi Xue Za Zhi; 1995 Mar; 18(1):36-42. PubMed ID: 7767852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.